Physician profile
Yan Qi
NPI 1982683090
$1,435.08
in general payments reported to CMS, 2019-2025
17 companies · $473 in 2025
The $473 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $80.79 · 2021: $71.74 · 2022: $26.01 · 2023: $284 · 2024: $92.11 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Consulting Fee: $150 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Consulting Fee | $150.00 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $251.09 | 2019-2025 | Tysabri, Vumerity |
| Teva Pharmaceuticals USA, INC. | $235.51 | 2019-2025 | |
| Genzyme Corporation | $200.00 | 2023 | |
| Supernus Pharmaceuticals, INC. | $197.45 | 2019 | |
| Amgen INC. | $157.69 | 2022-2025 | Uplizna |
| Abbvie INC. | $136.12 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $58.68 | 2020-2025 | |
| Adamas Pharmaceuticals, INC. | $28.45 | 2021 | |
| Boston Scientific Corporation | $27.28 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $25.57 | 2019 | |
| Acorda Therapeutics, INC | $23.97 | 2019 | |
| Ucb, INC. | $19.18 | 2024 | Rystiggo |
| Allergan, INC. | $18.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.33 | 2024 | Hyqvia |
| Pfizer INC. | $14.12 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $13.50 | 2024 | Rexulti |
| Celgene Corporation | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Qi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.